-+ 0.00%
-+ 0.00%
-+ 0.00%

HSBC Downgrades Eli Lilly to Reduce, Lowers Price Target to $700

Benzinga·04/28/2025 11:32:18
Listen to the news
HSBC analyst Rajesh Kumar downgrades Eli Lilly (NYSE:LLY) from Buy to Reduce and lowers the price target from $1150 to $700.